Investigational drug · Phase 2
Dispensing Codivir
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for HIV, HIV Infection.
Phase 2Last checked: Nov 19, 2026Latest source record: Nov 6, 2024 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "Dispensing Codivir"
First trial start
2023
Jul 20, 2023
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "Dispensing Codivir", any sponsor or status.
Conditions studied
As listed on its trial records.
- HIV
- HIV Infection
Approved drugs for the same conditions: Infectious disease and vaccines
Largest trials
Live from ClinicalTrials.gov: studies naming "Dispensing Codivir" as an intervention, largest first.
Code PharmaIndustry
NCT06676410 · 40 participants (planned) · Start Jul 20, 2023 · Primary completion Dec 2024
Drug: Dispensing Codivir®; Antiretrovirals · For: HIV; HIV Infection
Sites: São Paulo, Brazil
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for HIV
- AlimatravirMK-8527Phase 34 trials
Merck & Co. · Human Immunodeficiency Virus (HIV), HIV Pre-Exposure Prophylaxis, HIV
- LipovirtidePhase 21 trial
Shanxi Kangbao Biological Product Co., Ltd. · HIV
- LP-98Phase 21 trial
Shanxi Kangbao Biological Product Co., Ltd. · HIV
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.